PureTech Health (PRTC) Current Deferred Revenue (2019 - 2021)
PureTech Health (PRTC) has disclosed Current Deferred Revenue for 3 consecutive years, with $65000.0 as the latest value for Q4 2021.
- Quarterly Current Deferred Revenue fell 95.58% to $65000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Dec 2021, down 95.58% year-over-year, with the annual reading at $65000.0 for FY2021, 95.58% down from the prior year.
- Current Deferred Revenue for Q4 2021 was $65000.0 at PureTech Health, down from $1.5 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $5.5 million in Q4 2019, with the low at $65000.0 in Q4 2021.
- Average Current Deferred Revenue over 3 years is $2.3 million, with a median of $1.5 million recorded in 2020.
- The sharpest move saw Current Deferred Revenue tumbled 73.11% in 2020, then crashed 95.58% in 2021.
- Over 3 years, Current Deferred Revenue stood at $5.5 million in 2019, then crashed by 73.11% to $1.5 million in 2020, then plummeted by 95.58% to $65000.0 in 2021.
- According to Business Quant data, Current Deferred Revenue over the past three periods came in at $65000.0, $1.5 million, and $5.5 million for Q4 2021, Q4 2020, and Q4 2019 respectively.